|
1
|
Marko J, Wolfman DJ, Aubin AL and
Sesterhenn IA: Testicular seminoma and its mimics: From the
radiologic pathology archives. Radiographics. 37:1085–1098.
2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Ghazarian AA, Trabert B, Devesa SS and
McGlynn KA: Recent trends in the incidence of testicular germ cell
tumors in the United States. Andrology. 3:13–18. 2015.PubMed/NCBI View
Article : Google Scholar
|
|
3
|
Fukawa T and Kanayama HO: Current
knowledge of risk factors for testicular germ cell tumors. Int J
Urol. 25:337–344. 2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Lau SK, Weiss LM and Chu PG: D2-40
immunohistochemistry in the differential diagnosis of seminoma and
embryonal carcinoma: A comparative immunohistochemical study with
KIT (CD117) and CD30. Mod Pathol. 20:320–325. 2007.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Medeiros F, Corless CL, Duensing A,
Hornick JL, Oliveira AM, Heinrich MC, Fletcher JA and Fletcher CD:
KIT-negative gastrointestinal stromal tumors: Proof of concept and
therapeutic implications. Am J Surg Pathol. 28:889–894.
2004.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Casali PG, Blay JY, Abecassis N, Bajpai J,
Bauer S, Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee
JVMG, et al: Gastrointestinal stromal tumours:
ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis,
treatment and follow-up. Ann Oncol. 33:20–33. 2022.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Ibrahim A and Montgomery EA:
Gastrointestinal stromal tumors: Variants and some pitfalls that
they create. Adv Anat Pathol. 31:354–363. 2024.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Pai T, Bal M, Shetty O, Gurav M, Ostwal V,
Ramaswamy A, Ramadwar M and Desai S: Unraveling the spectrum of KIT
mutations in gastrointestinal stromal tumors: An Indian tertiary
cancer center experience. South Asian J Cancer. 6:113–117.
2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Calibasi G, Baskin Y, Alyuruk H, Cavas L,
Oztop I, Sagol O, Atila K, Ellidokuz H and Yilmaz U: Molecular
analysis of the KIT gene in gastrointestinal stromal tumors with
novel mutations. Appl Immunohistochem Mol Morphol. 22:37–45.
2014.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Lasota J, Corless CL, Heinrich MC,
Debiec-Rychter M, Sciot R, Wardelmann E, Merkelbach-Bruse S,
Schildhaus HU, Steigen SE, Stachura J, et al: Clinicopathologic
profile of gastrointestinal stromal tumors (GISTs) with primary KIT
exon 13 or exon 17 mutations: A multicenter study on 54 cases. Mod
Pathol. 21:476–484. 2008.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Serrano C, Bauer S, Gómez-Peregrina D,
Kang YK, Jones RL, Rutkowski P, Mir O, Heinrich MC, Tap WD,
Newberry K, et al: Circulating tumor DNA analysis of the phase III
VOYAGER trial: KIT mutational landscape and outcomes in patients
with advanced gastrointestinal stromal tumor treated with
avapritinib or regorafenib. Ann Oncol. 34:615–625. 2023.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Du J, Wang S, Wang R, Wang SY, Han Q, Xu
HT, Yang P and Liu Y: Identifying secondary mutations in Chinese
patients with Imatinib-resistant gastrointestinal stromal tumors
(GISTs) by next generation sequencing (NGS). Pathol Oncol Res.
26:91–100. 2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Lennartsson J and Rönnstrand L: Stem cell
factor receptor/c-Kit: From basic science to clinical implications.
Physiol Rev. 92:1619–1649. 2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
McIntyre A, Summersgill B, Grygalewicz B,
Gillis AJ, Stoop J, van Gurp RJ, Dennis N, Fisher C, Huddart R,
Cooper C, et al: Amplification and overexpression of the KIT gene
is associated with progression in the seminoma subtype of
testicular germ cell tumors of adolescents and adults. Cancer Res.
65:8085–8089. 2005.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Kemmer K, Corless CL, Fletcher JA,
McGreevey L, Haley A, Griffith D, Cummings OW, Wait C, Town A and
Heinrich MC: KIT mutations are common in testicular seminomas. Am J
Pathol. 164:305–313. 2004.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Nakhaei-Rad S, Soleimani Z, Vahedi S and
Gorjinia Z: Testicular germ cell tumors: Genomic alternations and
RAS-dependent signaling. Crit Rev Oncol Hematol.
183(103928)2023.PubMed/NCBI View Article : Google Scholar
|
|
17
|
de Vries G, Rosas-Plaza X, van Vugt MATM,
Gietema JA and de Jong S: Testicular cancer: Determinants of
cisplatin sensitivity and novel therapeutic opportunities. Cancer
Treat Rev. 88(102054)2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Galvez-Carvajal L, Sanchez-Muñoz A,
Ribelles N, Saez M, Baena J, Ruiz S, Ithurbisquy C and Alba E:
Targeted treatment approaches in refractory germ cell tumors. Crit
Rev Oncol Hematol. 143:130–138. 2019.PubMed/NCBI View Article : Google Scholar
|
